Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 110
of 6Next
1:

Estrogen receptor-dependent activation of AP-1 via non-genomic signalling.

Björnström L, Sjöberg M.

Nucl Recept. 2004 Jun 14;2(1):3.

PMID: 15196329 [PubMed - as supplied by publisher]

2:

Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.

Gougelet A, Mueller SO, Korach KS, Renoir JM.

J Steroid Biochem Mol Biol. 2007 May;104(3-5):110-22. Epub 2007 Mar 12.

PMID: 17478088 [PubMed - indexed for MEDLINE]

3:

Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.

Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS.

Mol Cell Endocrinol. 2003 Aug 29;206(1-2):13-22.

PMID: 12943986 [PubMed - indexed for MEDLINE]

4:

SKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1.

Walters MR, Dutertre M, Smith CL.

J Biol Chem. 2002 Jan 18;277(3):1669-79. Epub 2001 Nov 7.

PMID: 11700319 [PubMed - indexed for MEDLINE]

5:

Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions.

Björnström L, Sjöberg M.

Mol Endocrinol. 2002 Oct;16(10):2202-14.

PMID: 12351686 [PubMed - indexed for MEDLINE]

6:

Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha.

Maruyama S, Fujimoto N, Asano K, Ito A.

J Steroid Biochem Mol Biol. 2001 Aug;78(2):177-84.

PMID: 11566442 [PubMed - indexed for MEDLINE]

7:

Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.

Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA.

Mol Endocrinol. 1999 Mar;13(3):418-30.

PMID: 10076999 [PubMed - indexed for MEDLINE]

8:

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.

J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. Review.

PMID: 11162936 [PubMed - indexed for MEDLINE]

9:

The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.

Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S, Kushner PJ.

Mol Endocrinol. 1999 Oct;13(10):1672-85.

PMID: 10517669 [PubMed - indexed for MEDLINE]

10:

Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.

Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.

Cancer Res. 2002 Sep 1;62(17):4977-84.

PMID: 12208749 [PubMed - indexed for MEDLINE]

11:

Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.

Zhou S, Turgeman G, Harris SE, Leitman DC, Komm BS, Bodine PV, Gazit D.

Mol Endocrinol. 2003 Jan;17(1):56-66.

PMID: 12511606 [PubMed - indexed for MEDLINE]

12:

Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.

Weatherman RV, Clegg NJ, Scanlan TS.

Chem Biol. 2001 May;8(5):427-36.

PMID: 11358690 [PubMed - indexed for MEDLINE]

13:

Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.

van de Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C, Seasholtz AF, van der Saag PT.

Mol Endocrinol. 2004 Dec;18(12):2908-23. Epub 2004 Sep 2.

PMID: 15345745 [PubMed - indexed for MEDLINE]

14:

Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1.

Cheung E, Acevedo ML, Cole PA, Kraus WL.

Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):559-64. Epub 2005 Jan 10.

PMID: 15642950 [PubMed - indexed for MEDLINE]

15:

Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line.

Gottfried-Blackmore A, Croft G, McEwen BS, Bulloch K.

Brain Res. 2007 Dec;1186:41-7. Epub 2007 Oct 23.

PMID: 18021758 [PubMed - indexed for MEDLINE]

16:

17beta-estradiol-dependent activation of signal transducer and activator of transcription-1 in human fetal osteoblasts is dependent on Src kinase activity.

Kennedy AM, Shogren KL, Zhang M, Turner RT, Spelsberg TC, Maran A.

Endocrinology. 2005 Jan;146(1):201-7. Epub 2004 Oct 7.

PMID: 15471961 [PubMed - indexed for MEDLINE]

17:

Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.

Li X, Huang J, Yi P, Bambara RA, Hilf R, Muyan M.

Mol Cell Biol. 2004 Sep;24(17):7681-94.

PMID: 15314175 [PubMed - indexed for MEDLINE]

18:

Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.

Salvatori L, Pallante P, Ravenna L, Chinzari P, Frati L, Russo MA, Petrangeli E.

Oncogene. 2003 Jul 31;22(31):4875-81.

PMID: 12894229 [PubMed - indexed for MEDLINE]

20:

Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells.

Horner-Glister E, Maleki-Dizaji M, Guerin CJ, Johnson SM, Styles J, White IN.

J Mol Endocrinol. 2005 Dec;35(3):421-32.

PMID: 16326830 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 110
of 6Next